Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 15 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.72 Insider Own2.91% Shs Outstand5.32M Perf Week-3.97%
Market Cap38.20M Forward P/E- EPS next Y-0.06 Insider Trans0.00% Shs Float5.19M Perf Month-10.19%
Income-8.97M PEG- EPS next Q-0.78 Inst Own8.94% Short Float2.58% Perf Quarter22.89%
Sales7.67M P/S4.98 EPS this Y68.15% Inst Trans-63.19% Short Ratio2.73 Perf Half Y129.58%
Book/sh4.51 P/B1.58 EPS next Y94.00% ROA-30.16% Short Interest0.13M Perf Year59.73%
Cash/sh4.60 P/C1.55 EPS next 5Y- ROE-32.08% 52W Range2.31 - 11.79 Perf YTD155.91%
Dividend Est.- P/FCF- EPS past 5Y19.47% ROI-37.44% 52W High-39.44% Beta1.11
Dividend TTM- Quick Ratio16.99 Sales past 5Y-67.27% Gross Margin99.58% 52W Low209.08% ATR (14)0.77
Dividend Ex-Date- Current Ratio16.99 EPS Y/Y TTM20.42% Oper. Margin-96.57% RSI (14)45.86 Volatility4.71% 14.69%
Employees17 Debt/Eq0.00 Sales Y/Y TTM1282.40% Profit Margin-116.89% Recom1.00 Target Price33.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q186.73% Payout- Rel Volume1.20 Prev Close7.69
Sales Surprise- EPS Surprise196.75% Sales Q/Q13751.93% EarningsMay 09 BMO Avg Volume49.02K Price7.14
SMA20-11.87% SMA502.31% SMA20062.63% Trades Volume58,814 Change-7.15%
Date Action Analyst Rating Change Price Target Change
Jun-24-21Initiated Cantor Fitzgerald Overweight $3
Dec-10-20Upgrade Ladenburg Thalmann Neutral → Buy $3
Jan-12-18Reiterated H.C. Wainwright Buy $10 → $3
Jan-11-18Downgrade Canaccord Genuity Buy → Hold $11 → $2
Dec-08-17Resumed H.C. Wainwright Buy $10
Oct-07-16Initiated H.C. Wainwright Buy $25
Jul-22-15Initiated ROTH Capital Buy $36
Jun-23-15Initiated Canaccord Genuity Buy $15
Jun-25-24 08:00AM
Jun-10-24 08:00AM
Jun-06-24 08:50AM
May-28-24 06:10AM
May-21-24 08:50AM
01:53PM Loading…
May-09-24 01:53PM
May-08-24 08:00AM
May-01-24 08:00AM
Apr-11-24 07:00AM
Mar-28-24 08:00AM
Mar-25-24 08:00AM
Mar-07-24 02:52PM
08:00AM Loading…
Mar-06-24 08:00AM
Feb-06-24 08:00AM
Feb-02-24 08:00AM
Jan-18-24 08:00AM
Dec-19-23 08:00AM
Nov-13-23 02:45PM
Nov-08-23 08:17AM
Nov-01-23 08:00AM
Oct-26-23 08:00AM
Oct-23-23 07:00PM
Sep-19-23 04:05PM
Aug-16-23 06:02AM
Aug-10-23 08:09AM
06:13AM Loading…
Jul-31-23 06:13AM
Jul-27-23 06:30AM
Jun-14-23 08:00AM
Jun-07-23 08:00AM
May-19-23 09:14AM
May-16-23 07:00AM
May-11-23 06:23AM
Apr-03-23 08:00AM
Mar-16-23 06:00AM
Mar-10-23 08:30AM
Jan-16-23 08:06AM
Jan-05-23 08:00AM
Dec-19-22 08:00AM
Nov-30-22 04:28AM
Nov-09-22 08:00AM
Nov-03-22 08:00AM
Oct-11-22 08:00AM
Sep-27-22 01:21PM
Sep-26-22 11:39AM
Sep-22-22 04:10PM
Sep-15-22 08:00AM
Aug-10-22 06:04AM
Aug-09-22 06:41AM
Aug-08-22 08:00AM
Jul-11-22 08:00AM
Jun-14-22 08:00AM
Jun-06-22 04:00PM
May-20-22 07:12AM
May-12-22 10:55AM
May-10-22 11:30AM
May-09-22 08:00AM
May-04-22 06:34AM
Apr-11-22 08:00AM
Mar-29-22 07:34PM
Mar-11-22 04:26AM
Mar-09-22 08:00AM
Mar-01-22 08:00AM
Feb-25-22 07:42AM
Feb-03-22 08:00AM
Jan-27-22 08:00AM
Jan-05-22 08:00AM
Dec-22-21 08:00AM
Nov-19-21 09:04AM
Nov-11-21 10:00AM
Nov-10-21 08:00AM
Nov-08-21 08:18AM
Nov-04-21 08:00AM
Nov-01-21 08:00AM
Oct-19-21 07:00AM
Oct-18-21 12:15PM
Oct-05-21 08:00AM
Sep-28-21 08:00AM
Sep-20-21 08:00AM
Sep-01-21 08:00AM
Aug-31-21 05:43AM
Aug-25-21 06:30AM
Aug-09-21 07:12AM
Aug-05-21 08:00AM
Jul-15-21 09:00AM
Jul-14-21 04:00PM
Jul-06-21 08:00AM
Jun-23-21 08:00AM
Jun-16-21 08:00AM
Jun-14-21 08:00AM
Lipocine, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of the delivery of drugs using proprietary delivery technology. It offers TLANDO, an oral testosterone replacement therapy. The company was founded on October 13, 2011 and is headquartered in Salt Lake City, UT.